Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01339039
Title Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Patrick Y. Wen, MD
Age Groups: adult
Covered Countries USA

No variant requirements are available.